Insider transactions

EDGAR

BIOFORCE NANOSCIENCES HOLDINGS, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-19.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
1 transactions, 26,700,000 shares
Sum of shares × price per share: 400,500

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–6 of 6

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-08-31 Filed 2026-09-02KAISER RICHARD KAISER Director · Officer: CEO CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock; Par Value $0.001
Acquired (A)316,9090.55
174,299.95

Derived: shares × price per share. Exact value 174299.95.

1,234,447Direct (D) No
F3
  • F3 Reporting person received restricted shares in lieu of cash on a portion of accrued wages owed by the Company through April 30, 2026.
Open filing 0001091818-26-000133 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-09-02KAISER RICHARD KAISER Director · Officer: CEO CFO
J

Other acquisition or disposition (describe transaction)

Common Stock; Par Value $0.001
Disposed (D)38,4620.65
25,000.3

Derived: shares × price per share. Exact value 25000.30.

917,538Direct (D) No
F2
  • F2 Reporting person paid a residential landscape contractor in shares in lieu of cash on an outstanding promissory note that was entered into in 2020 for the amount of $25,000.
Open filing 0001091818-26-000133 Read from the filing’s XML Dispute this row
2026-04-22 Filed 2026-09-02Ferguson Merle Director
S

Open market or private sale of non-derivative or derivative security

Common Stock; Par Value $0.001
Disposed (D)26,700,0000.015
400,500

Derived: shares × price per share. Exact value 400500.000.

0Direct (D) No— Open filing 0001091818-26-000134 Read from the filing’s XML Dispute this row
2026-04-20 Filed 2026-09-02KAISER RICHARD KAISER Director · Officer: CEO CFO
G

Bona fide gift

Common Stock; Par Value $0.001
Disposed (D)4,132,0000.001
4,132

Derived: shares × price per share. Exact value 4132.000.

956,000Direct (D) No
F1
  • F1 38,000 shares of this amount are held in YES INTERNATIONAL's name, an LLC that is 100% controlled by the reporting individual
Open filing 0001091818-26-000133 Read from the filing’s XML Dispute this row
2026-04-20 Filed 2026-09-02Ferguson Merle Director
G

Bona fide gift

Common Stock; Par Value $0.001
Acquired (A)20,580,0000.007
144,060

Derived: shares × price per share. Exact value 144060.000.

22,568,000Direct (D) No— Open filing 0001091818-26-000134 Read from the filing’s XML Dispute this row
2026-04-20 Filed 2026-09-02Ferguson Merle Director
G

Bona fide gift

Common Stock; Par Value $0.001
Acquired (A)4,132,0000.001
4,132

Derived: shares × price per share. Exact value 4132.000.

26,700,000Direct (D) No— Open filing 0001091818-26-000134 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Nexus Capital Investments, Inc. Common Stock, par value $0.001 per share79.626,700,000.0004/22/2026 Filed 2026-09-04SCHEDULE 13DOpen filing 0001091818-26-000141 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,544,215 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020170,508
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,403

Filings made before the SEC required XML are listed, not extracted.

Back to BIOFORCE NANOSCIENCES HOLDINGS, INC.